Japan Nods Include Global Firsts For Duvroq, Vafseo And First Local Biosimilar Humira
Plus Five-Product Bonanza For Novartis
Japan’s regulators have approved a large batch of new products, including a novel antibody from Chugai, two world-first nods for the country’s second HIF-PH inhibitors and an asthma therapy, and the first Humira biosimilar in Japan – as well as five drugs from Novartis.
